Recombinant antigens

B13
for Trypanosoma cruzi

B13 protein is an immunodominant recombinant antigen which encodes part of the tandemly repeated domain of the Trypanosoma cruzi. It is a 140/116 kDa protein located on the surface of infective trypomastigotes from several strains.

NAME
B13
DESCRIPTION
CA-2 surface antigen. Also known as Ag2, PEP2, TcR34
GEN
B13
PURITY
>95% by observation on SDS-PAGE electrophoresis
Formats

Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format

* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.

References of Recombinant antigen B13

RAG0103

SOURCE
E. coli
APPLICATIONS
WB Western Blot, DB: Dot Blot, IE: Indirect ELISA, DE: positive control in Direct ELISA, CLIA: Chemiluminescent immunoassay, LF: Lateral-Flow
VALIDACIÓN IN-HOUSE
ELISA

Folletos

Videos

Related proteins

1F8

  • RAG0003

Recombinant antigen B13 for Trypanosoma cruzi
Calcium-binding flagellar antigen

SEE MORE

ChimChagas1

  • RAG0093 (chimera)

Recombinant antigen B13 for Trypanosoma cruzi
Multi-epitope recombinant chimeric antigen for Chagas

SEE MORE

ChimChagas2

  • RAG0094 (chimera)
  • RAG0094BIOT (biotinylated, chimera)

Recombinant antigen B13 for Trypanosoma cruzi
Multi-epitope recombinant chimeric antigen for Chagas

SEE MORE

ChimChagas3

  • RAG0096 (chimera)
  • RAG0096BIOT (biotinylated, chimera)

Recombinant antigen B13 for Trypanosoma cruzi
Multi-epitope recombinant chimeric antigen for Chagas

SEE MORE

FRA

  • RAG0005
  • RAG0005BIOT (biotinylated)

Recombinant antigen B13 for Trypanosoma cruzi
Cytoskeleton associated antigen. Also known as Ag1, JL7, H49

SEE MORE

Related antibodies

Anti-Chagas

  • PAB0007

Recombinant antigen B13

SEE MORE

Reagent sheet

NAME
B13
DESCRIPTION
CA-2 surface antigen. Also known as Ag2, PEP2, TcR34
PURITY
>95% by observation on SDS-PAGE electrophoresis
Formats

Liquid solution or dry powder (lyophilised) in vials of 0.1 mg*, 1 mg and bulk.
*under availability, for liquid format

* Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. In addition, we follow a rigorous quality control for each lot.

Join as a distributor